GMP documentation – Page 13

Why Transcription Error Prevention Happens and How QA Teams Should Control It

Understanding and Controlling Transcription Errors in Hybrid Paper Electronic Systems In the realm of pharmaceutical manufacturing and quality control, transcription errors can pose significant risks to data integrity, regulatory compliance,…

GDP Errors in Batch Records and How to Prevent Them

Addressing GDP Errors in Batch Records: A Comprehensive Approach to Prevention In the highly regulated environment of pharmaceutical manufacturing, adherence to Good Documentation Practices (GDP) is non-negotiable. Errors in batch…

Inspection-Ready Approach to Hybrid Batch Record Governance in Pharmaceutical Operations

Effective Management of Hybrid Batch Record Systems in Pharmaceutical Manufacturing The adoption of hybrid batch record systems, integrating paper and electronic formats, raises significant challenges in maintaining data integrity under…

How to Apply ALCOA+ Principles in Daily GMP Documentation

Implementing ALCOA+ Principles for Effective GMP Documentation in Pharma Operations In pharmaceutical manufacturing and quality assurance, maintaining robust documentation practices is critical to ensuring compliance and data integrity. Despite the…

Paper Copy vs Electronic Source of Truth: Root Causes, GMP Risks, and CAPA Controls

Investigating Root Causes and Risks of Hybrid Paper and Electronic GMP Records In the pharmaceutical industry, maintaining data integrity is paramount, especially in hybrid systems that combine paper and electronic…

Good Documentation Practices in Pharma: Practical GDP and ALCOA+ Guide

Addressing Documentation Challenges in Pharmaceutical Operations: A Practical Guide to GDP and ALCOA+ The pharmaceutical industry operates under stringent regulatory standards, where good documentation practices (GDP) are crucial. However, instances…

How to Prevent Controlled Printout Risks in Hybrid Paper–Electronic Systems

Mitigating Risks Associated with Controlled Printouts in Hybrid Paper–Electronic Systems The increasing adoption of hybrid paper–electronic systems in pharmaceutical operations presents specific challenges, particularly concerning controlled printout risks. These risks…

Inspection Readiness for Artwork and Labeling Records

Ensuring Compliance in Artwork Control and Regulatory Review In the fast-paced pharmaceutical industry, effective artwork control and thorough regulatory review are critical to ensure compliance and product integrity. Mislabeling or…

Packaging Artwork CAPA After Recall or Market Complaint

Addressing Packaging Artwork CAPA After a Recall or Market Complaint Pharmaceutical manufacturers face significant challenges when defects arise in packaging artwork, leading to recalls or market complaints. These issues can…

Artwork Lifecycle Management After Product Approval

Managing Artwork Lifecycle Post-Approval: A Comprehensive Approach In the pharmaceutical industry, the management of artwork post-product approval can often lead to significant challenges. Poorly controlled artwork changes can result in…

How to Align Artwork, BOM, and Packaging Specifications

Steps to Ensure Alignment of Artwork, BOM, and Packaging Specifications In the complex world of pharmaceutical manufacturing, maintaining compliance with artwork control and regulatory review is essential to ensure product…

Artwork Control and Data Integrity in Packaging Operations

Effective Strategies for Managing Artwork Control and Regulatory Review in Pharmaceutical Packaging In the high-stakes environment of pharmaceutical packaging, managing artwork control and regulatory review is critical for compliance and…